Michigan House Bill HB5050

Michigan 2025-2026 Regular Session

• Introduced: 9/24/25
• Refer: 9/24/25
• Report Pass: 11/5/25
• Report Pass: 12/16/25
• Engrossed: 12/17/25
• Refer: 1/14/26

Caption

Health: pharmaceuticals; administration of epinephrine; modify. Amends secs. 17744a & 17744d of 1978 PA 368 (MCL 333.17744a & 333.17744d). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5051'25, HB 5052'25, HB 5053'25

Impact

The bill's amendments are expected to enhance public safety by enabling more entities to stock and administer epinephrine. It encourages proactive emergency preparedness, particularly in environments with a higher risk of allergic reactions, like schools and sports events. Furthermore, the legislation includes civil liability protections for those administering epinephrine, thus promoting greater participation among trained staff and personnel in emergencies without fear of legal repercussions.

Summary

House Bill 5050 aims to amend the Public Health Code in Michigan by allowing prescribers to issue prescriptions for auto-injectable epinephrine delivery systems to various authorized entities. This includes schools, recreational camps, and other organizations where allergens may be present. Under the provisions of this bill, authorized individuals such as trained school staff, law enforcement, and firefighters will be permitted to administer epinephrine to individuals experiencing anaphylaxis, significantly broadening the capacity for timely emergency responses in allergic situations.

Sentiment

Overall, the sentiment surrounding HB 5050 appears to be positive, particularly among public health advocates and educational institutions concerned with student safety. The bill is viewed as a necessary step in addressing the serious health risks posed by anaphylaxis in everyday environments. However, there are concerns from some stakeholders about ensuring adequate training for personnel who will be administering epinephrine, emphasizing the need for comprehensive anaphylaxis training programs to ensure safety and efficacy in emergency situations.

Contention

Notable points of contention include discussions around the adequacy of training for staff who will administer the epinephrine and the potential for misuse or unintended consequences if the protocols are not followed correctly. Critics urge that the bill must ensure robust training standards and accountability to protect both the individuals administering the drug and those receiving it. Additionally, some fears are expressed about the potential increase in civil liability concerns if exceptions or loopholes are found within the legislative framework.